Guangzhou Baiy reported CNY37.86B in Current Liabilities for its fiscal quarter ending in June of 2025.


Current Liabilities Change Date
Aspen Pharmacare ZAR 17.25B 7.13B Dec/2024
Cipla INR 54.84B 291.6M Mar/2025
Dr.Reddys Laboratories INR 142.59B 12.25B Jun/2025
Jiangsu Hengrui CNY 3.47B 102.17M Jun/2025
Kalbe Farma IDR 4.65T 461.98B Jun/2025
Richter Gedeon HUF 175.24B 34.29B Dec/2024
Sh Fosun Pharma CNY 36.02B 522.8M Jun/2025
Sh Pharmaceutical CNY 140.13B 9.32B Jun/2025
Sun Pharmaceuticals INR 181.94B 9.39B Mar/2025
Teva Pharmaceutical Industries USD 11.86B 704M Jun/2025